Viking Therapeutics VKTX is one of the few companies with a late-stage obesity candidate in its pipeline. The company is ...

Adolescents with overweight or obesity and asthma taking a GLP-1 agent had less risk of asthma exacerbations compared with ...

GLP-1 agonists are pivotal in obesity care, promoting weight loss and addressing related health issues, with a focus on ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) like semaglutide and liraglutide mimic endogenous incretin signals to stimulate glucose-dependent insulin release, thereby suppressing glucagon, ...

The discovery of GLP-1 and its role in regulating blood glucose was a major scientific breakthrough in diabetes research, yet turning this peptide hormone into an effective medication was no easy task ...

Please provide your email address to receive an email when new articles are posted on . GLP-1 receptor agonists and fenofibrate medications significantly reduced the risk for developing diabetic ...

Researchers are studying whether these widely used weight-loss drugs may also be future treatments for alcohol abuse.

Researchers have been examining other potential health benefits from GLP-1 agonist medications outside of type 2 diabetes management and weight loss. Recent studies have found that GLP-1 medications ...

As use of GLP-1 receptor agonists (RAs) continues to rise exponentially, awareness of its most common side effects, such as nausea and vomiting, is growing. But the drugs come with some lesser-known ...